[1]
“Evaluation of the PGAxBSA Composite Tool in Patients with Moderate-to-Severe Plaque Psoriasis”, J of Skin, vol. 1, no. 3.1, p. s14, Oct. 2017, doi: 10.25251/skin.1.supp.13.